EVENTS | VIEW CALENDAR
Sigma-Aldrich acquires Research Organics, strengthens portfolio of PharmaGrade raw materials
ST. LOUIS—Sigma-Aldrich Corp. announced in April that it has acquired all outstanding shares of Cleveland, Ohio-based, Research Organics Inc., to expand the company's buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets.
Founded in the 1950s, Research Organics was a pioneer in manufacturing zwitterionic biological buffers and developing the HEPES buffer as an industry standard. Research Organics is now a supplier of high-purity biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences and biotechnology, and will transition into SAFC, the custom manufacturing and services business unit of Sigma-Aldrich.
Financial terms of the purchase were not disclosed. Sigma-Aldrich said it expects the acquisition to be neutral to earnings per share in 2012.
"This acquisition is an outstanding complement to our existing raw materials portfolio and will help us provide more innovative solutions for some of our customers' toughest supply challenges," said Gilles Cottier, executive vice president of Sigma-Aldrich and president of SAFC, in a statement. "It will also enable us to provide SAFC's customers with true dual sourcing of buffers from two of the world's leading manufacturing sites."
"Joining Sigma-Aldrich is positive for Research Organics, our employees, customers and the city of Cleveland," added Rob Sternfeld, president of Research Organics. "The acquisition provides the resources to expand the growth of our business, to enhance our product line and to upgrade our facilities to meet ever changing industry requirements. We will continue to provide our customers with the superior quality and service they deserve and have come to expect."